BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15978617)

  • 1. Crystal structure of the ENT domain of human EMSY.
    Chavali GB; Ekblad CM; Basu BP; Brissett NC; Veprintsev D; Hughes-Davies L; Kouzarides T; Itzhaki LS; Doherty AJ
    J Mol Biol; 2005 Jul; 350(5):964-73. PubMed ID: 15978617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of EMSY to HP1beta: implications for recruitment of HP1beta and BS69.
    Ekblad CM; Chavali GB; Basu BP; Freund SM; Veprintsev D; Hughes-Davies L; Kouzarides T; Doherty AJ; Itzhaki LS
    EMBO Rep; 2005 Jul; 6(7):675-80. PubMed ID: 15947784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of an ENT domain from Trypanosoma brucei.
    Mi J; Yang X; Zhang J; Zhang X; Xu C; Liao S; Tu X
    Biochem Biophys Res Commun; 2018 Nov; 505(3):755-760. PubMed ID: 30293681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer.
    Hughes-Davies L; Huntsman D; Ruas M; Fuks F; Bye J; Chin SF; Milner J; Brown LA; Hsu F; Gilks B; Nielsen T; Schulzer M; Chia S; Ragaz J; Cahn A; Linger L; Ozdag H; Cattaneo E; Jordanova ES; Schuuring E; Yu DS; Venkitaraman A; Ponder B; Doherty A; Aparicio S; Bentley D; Theillet C; Ponting CP; Caldas C; Kouzarides T
    Cell; 2003 Nov; 115(5):523-35. PubMed ID: 14651845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the amino-terminal coiled-coil domain of the APC tumor suppressor.
    Day CL; Alber T
    J Mol Biol; 2000 Aug; 301(1):147-56. PubMed ID: 10926498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. POU domain factors in neural development.
    Schonemann MD; Ryan AK; Erkman L; McEvilly RJ; Bermingham J; Rosenfeld MG
    Adv Exp Med Biol; 1998; 449():39-53. PubMed ID: 10026784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dimerization domain of HNF-1alpha: structure and plasticity of an intertwined four-helix bundle with application to diabetes mellitus.
    Narayana N; Hua Q; Weiss MA
    J Mol Biol; 2001 Jul; 310(3):635-58. PubMed ID: 11439029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The function of EMSY in cancer development.
    Hou J; Wang Z; Yang L; Guo X; Yang G
    Tumour Biol; 2014 Jun; 35(6):5061-6. PubMed ID: 24609898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron(II) triggered conformational changes in Escherichia coli fur upon DNA binding: a study using molecular modeling.
    Hamed MY; Al-Jabour S
    J Mol Graph Model; 2006 Oct; 25(2):234-46. PubMed ID: 16443380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of a heat-inducible transcriptional repressor HrcA from Thermotoga maritima: structural insight into DNA binding and dimerization.
    Liu J; Huang C; Shin DH; Yokota H; Jancarik J; Kim JS; Adams PD; Kim R; Kim SH
    J Mol Biol; 2005 Jul; 350(5):987-96. PubMed ID: 15979091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of FadR, a fatty acid-responsive transcription factor with a novel acyl coenzyme A-binding fold.
    van Aalten DM; DiRusso CC; Knudsen J; Wierenga RK
    EMBO J; 2000 Oct; 19(19):5167-77. PubMed ID: 11013219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the HP1-EMSY complex reveals an unusual mode of HP1 binding.
    Huang Y; Myers MP; Xu RM
    Structure; 2006 Apr; 14(4):703-12. PubMed ID: 16615912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of AmtR, the global nitrogen regulator of Corynebacterium glutamicum, in free and DNA-bound forms.
    Palanca C; Rubio V
    FEBS J; 2016 Mar; 283(6):1039-59. PubMed ID: 26744254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMSY links breast cancer gene 2 to the 'Royal Family'.
    Yao J; Polyak K
    Breast Cancer Res; 2004; 6(5):201-3. PubMed ID: 15318925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry.
    Bane AL; Mulligan AM; Pinnaduwage D; O'Malley FP; Andrulis IL
    Breast Cancer Res Treat; 2011 Jun; 127(3):831-9. PubMed ID: 21327470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxyl-terminal domain dimer interface mutant 434 repressors have altered dimerization and DNA binding specificities.
    Donner AL; Paa K; Koudelka GB
    J Mol Biol; 1998 Nov; 283(5):931-46. PubMed ID: 9799634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
    Määttä KM; Nurminen R; Kankuri-Tammilehto M; Kallioniemi A; Laasanen SL; Schleutker J
    BMC Cancer; 2017 Jul; 17(1):496. PubMed ID: 28738860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The putative DNA-binding protein Sto12a from the thermoacidophilic archaeon Sulfolobus tokodaii contains intrachain and interchain disulfide bonds.
    Shinkai A; Sekine S; Urushibata A; Terada T; Shirouzu M; Yokoyama S
    J Mol Biol; 2007 Oct; 372(5):1293-304. PubMed ID: 17720190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complex formed between Tet repressor and tetracycline-Mg2+ reveals mechanism of antibiotic resistance.
    Kisker C; Hinrichs W; Tovar K; Hillen W; Saenger W
    J Mol Biol; 1995 Mar; 247(2):260-80. PubMed ID: 7707374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations.
    Navazio AS; Rizzolo P; Silvestri V; Valentini V; Zelli V; Zanna I; Masala G; Bianchi S; Tommasi S; Palli D; Ottini L
    Breast Cancer Res Treat; 2016 Nov; 160(1):181-186. PubMed ID: 27628328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.